BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90//
CALSCALE:GREGORIAN
UID:37373863-3661-4439-b734-336133666338
BEGIN:VEVENT
UID:d179a5551d6f71d5b13d2e3adba2fef529eb77eb@swoogo.com
DTSTAMP:20260517T113251Z
DESCRIPTION:Medications for opioid use disorder remain underutilized in U.S
 . carceral settings\, largely due to staffing burdens tied to daily dosing
 . This study used a cost impact model to evaluate staff time and cost diff
 erences across MOUD types\, including methadone\, oral buprenorphine\, ext
 ended-release buprenorphine\, and naltrexone. Findings suggest that using 
 long-acting injectable MOUD\, such as BUP-XR\, may significantly reduce st
 affing time and costs\, improving treatment feasibility in correctional en
 vironments.
DTSTART:20250720T070000Z
DTEND:20250720T070000Z
LAST-MODIFIED:20260517T113251Z
LOCATION:East Lounge Foyer
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:208 A Cost Model for the Impact of MOUD on Staffing
TRANSP:OPAQUE
X-ALT-DESC;FMTTYPE=text/html:<p>Medications for opioid use disorder remain 
 underutilized in U.S. carceral settings\, largely due to staffing burdens 
 tied to daily dosing. This study used a cost impact model to evaluate staf
 f time and cost differences across MOUD types\, including methadone\, oral
  buprenorphine\, extended-release buprenorphine\, and naltrexone. Findings
  suggest that using long-acting injectable MOUD\, such as BUP-XR\, may sig
 nificantly reduce staffing time and costs\, improving treatment feasibilit
 y in correctional environments.</p>
BEGIN:VALARM
UID:36633630-6234-4663-b933-663032343237
ACTION:DISPLAY
DESCRIPTION:Medications for opioid use disorder remain underutilized in U.S
 . carceral settings\, largely due to staffing burdens tied to daily dosing
 . This study used a cost impact model to evaluate staff time and cost diff
 erences across MOUD types\, including methadone\, oral buprenorphine\, ext
 ended-release buprenorphine\, and naltrexone. Findings suggest that using 
 long-acting injectable MOUD\, such as BUP-XR\, may significantly reduce st
 affing time and costs\, improving treatment feasibility in correctional en
 vironments.
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR